Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an effective treatment that can dramatically reduce daily doses or even eliminate dependence on external insulin. Insulin producing cells are injected into a recipient liver. After an adaptation period they start to produce sufficient hormone needed by diabetic patients.
However, while the transplantation procedure itself has been greatly improved in recent years, collection, preservation, and transportation of these cells are still very challenging. Research published in Advanced Healthcare Materials by the scientists from the Okinawa Institute of Technology and Science Graduate University (OIST) in collaboration with the University of Washington and Wuhan University of Technology offers a solution for some of these problems.
Production and secretion of insulin occur in the pancreas — an endocrine gland in the digestive system. Cells secreting insulin are clustered in pancreatic islets. Despite their crucial role in organismal wellbeing these islets comprise only a few percent of the pancreatic tissue. The islet transplantation does not require major surgical intervention and is often done under local anaesthesia. It is also cheaper and might be safer than transplantation of the entire pancreas. Unfortunately, so far, only human islets can be transplanted and their supply is but a trickle.
Cryopreservation, or deep freezing, is the method commonly used for the islet preservation and transportation. But it is not completely safe. One might think that storage at temperatures below -190°C is the most dangerous phase. However, the cells are very good at enduring it. It is the freezing process (-15 to -60°C) itself that poses the most challenges. As the cells are cooled, water in and around them freezes. Ice crystals have sharp edges that can pierce membranes and compromise cell viability. This also becomes problematic during thawing.
A multidisciplinary group of researchers led by Prof. Amy Shen, head of the Micro/Bio/Nanofluidics Unit at OIST, developed a novel cryopreservation method that not only helps to protect pancreatic islets from ice damage, but also facilitates real-time assessments of cell viability. Moreover, this method may reduce transplant rejection and, in turn, decrease use of immunosuppressant drugs, which can be harmful to patient health.
The novel technique employs a droplet microfluidic device to encapsulate pancreatic islets in hydrogel made of alginate, a natural polymer extracted from seaweed. These capsules have a unique microstructure: a porous network and considerable amount of non-freezable water. There are three types of water in the hydrogel: free water, freezable bound water, and non-freezable bound water. Free water is regular water: it freezes at 0°C, producing ice crystals. Freezable bound water also crystallises, but the freezing point is lower. Non-freezable bound water does not form ice due to the strong association between water molecules and the hydrogel networks. Hydrogel capsules with large amounts of non-freezable bound water protect the cells from the ice damage and reduce the need for cryoprotectants — special substances that minimise or prevent freezing damage and can be toxic in high concentrations.
Another innovation, proposed by the group, is the use of a fluorescent oxygen-sensitive dye in hydrogel capsules. The porous structure of the capsules does not impede oxygen flow to the cells. And this dye functions as a real-time single-islet oxygen sensor. Fluorescence indicates whether cells are consuming oxygen and, therefore, are alive and healthy. It is a simple, time-efficient, and cheap method of assessing viability, both of individual islets or populations thereof.
Islet encapsulation reduces the risk of rejection of transplanted cells by the recipient. The hydrogel capsule allows small molecules, e.g. nutrients and islet secretions, to pass through the membrane easily, but prevents direct contact between implanted islets and host cells. Encapsulation also may prevent an attack on transplants by the autoimmune response that destroyed the patient’s own islets in the first place.
The microencapsulation method can help to overcome some major challenges in pancreatic islet transplantation, including the scarcity of available islets and the lack of simple and reliable control methods, especially for individual islet assessment. It offers hope to patients suffering from type 1 diabetes to return to a “normal” life, free of insulin injections.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd®on March 4, 2021 at 1:28 am
The upcoming Phase III trial with Diamyd® in new-onset type 1 diabetes will be based on the first precision medicine approach in the field.
- We've been wrong about how insulin has to be stored, and a new approach could revolutionize diabetes treatment for millions of peopleon March 3, 2021 at 9:30 pm
For people living with diabetes in the developing world, a lack of electricity can hamper access to insulin. But a project in Kenya has shown that insulin can be maintained in hot climates without ...
- Drug prevents, delays Type 1 diabetes in 50% of those at risk, study findson March 3, 2021 at 11:06 am
Half of those at risk for Type 1 diabetes treated with the drug teplizumab remained disease-free five years later, a study published Wednesday by the journal Science Translational Medicine found.
- Immunotherapy drug delays onset of Type 1 diabetes in at-risk groupon March 3, 2021 at 11:01 am
More than five years after receiving an experimental immunotherapy drug, half of a group of people at high risk of developing Type 1 diabetes remained disease-free compared with 22% of those who ...
- Type 2 diabetes symptoms: High blood sugar levels may cause abdominal painon March 3, 2021 at 3:28 am
TYPE 2 diabetes is a complicated condition and as with most complicated issues, being able to pinpoint the precise signs and symptoms may not always be obvious. Having high blood sugar levels can ...
- Aggressive intervention recommended to prevent pediatric diabeteson March 3, 2021 at 2:15 am
Type 2 diabetes, once considered an adult disease, is increasingly causing health complications among American youth. A research review published in the Journal of Osteopathic Medicine suggests ...
- Smaller Reproductive Window With Type 1 Diabeteson March 2, 2021 at 9:08 pm
Developing type 1 diabetes (T1D) in childhood was significantly associated with a shorter opportunity for childbearing, a new study showed. Women diagnosed with T1D in childhood had an average 2.5 ...
- Local mother urging state leaders to add Type 1 diabetes to comorbidities liston March 2, 2021 at 3:23 pm
There is a growing call to add Type 1 diabetes to the list of medical conditions that put people at higher risk for severe COVID-19 illness.
- Eating meat 'raises risk of heart disease, diabetes and pneumonia'on March 2, 2021 at 6:31 am
Eating meat regularly increases someone’s risk of developing heart disease, diabetes, pneumonia and other serious illnesses, new research has found. It is already known that intake of red and ...
- Diabetes, Obesity, Hypertension, and Cardiovascular Disease Linked to Most COVID-19 Hospitalizationson March 2, 2021 at 12:00 am
Researchers estimated that of the more than 900,000 COVID-19 hospitalizations that occurred in the United States through mid-November 2020, 30 percent could be attributed to obesity; 26 percent to ...
via Bing News